InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines BLDR Q1 2026 Earnings EPS Misses Estimates by 284 Stock Edges Higher AIRO Q4 2025 Earnings EPS Falls Far Short of Estimates Despite Stock Gain NU Q1 2026 Earnings EPS Misses Estimates Stock Declines on Profitability Concerns VLYPO Q1 2026 Earnings Preferred Series B Reports Strong EPS Beat as Valley National Bancorp Outperforms Estimates KG Q3 2024 Earnings Loss per Share of 016 Amid Limited Disclosure